With more than 100 investigational new drug applications (INDs) filed last year for gene-therapy products and multiple CAR T programs underway, consistent and reliable production of these therapies is needed to get treatments to patients.

Mustang Bio has built an industry-leading and proprietary CAR T manufacturing process and facility in Worcester, Mass capable of processing therapies with unrivaled quality for both clinical development and commercialization.

Features of this facility include:

  • Central location in biotech park
  • Fully equipped QC lab
  • Full research and PD lab
  • 4 separate cleanrooms

The new Mustang Advanced Research Site (MARS) facility

The facility also has an R&D center to develop new improvements in the manufacturing process to ensure that a high-quality and safe product gets to each and every patient.

To learn more about our manufacturing capabilities, or to inquire about utilizing Mustang Bio for your production needs, contact info@mustangbio.com.